Rajput grew up in Bangalore, India, and was initially interested in electrical engineering. After university, he spent a year at MIT’s Media lab in 2014, where his interest in biosensors, artificial intelligence, and health came together. During his time at MIT, Rajput built algorithms that were capable of detecting sleep apnea and cardiac arrhythmia.
In November, Biofourmis announced a collaboration with Novartis to use sensors and analytics to monitor patients in Southeast Asia, who are taking the heart failure drug Entresto. “Novartis is looking to transform medicine by looking into patient outcomes beyond our medicines,” Miguel Rivera, business model transformation head, Novartis Asia Cluster, said in an email.
SoftBank’s Vision Fund 2 investments come as the Japan-based holding company has struggled to find outside investors after its original $100 billion Vision Fund has seen a tumultuous couple of years. That has included high-profile flame-outs, including catastrophically overvaluing WeWork and backing Uber at a price that has seen SoftBank’s stake at times underwater.